209 institutions hold shares in Akebia Therapeutics Inc. (AKBA), with 2.01M shares held by insiders accounting for 1.31% while institutional investors hold 66.97% of the
Akebia Therapeutics Inc. (NASDAQ: AKBA) is 5.71% higher on its value in year-to-date trading and has touched a low of $2.09 and a high of
Akebia Therapeutics Inc. (NASDAQ: AKBA) is 6.43% higher on its value in year-to-date trading and has touched a low of $2.09 and a high of
208 institutions hold shares in Akebia Therapeutics Inc. (AKBA), with 2.09M shares held by insiders accounting for 1.36% while institutional investors hold 69.39% of the
207 institutions hold shares in Akebia Therapeutics Inc. (AKBA), with 2.09M shares held by insiders accounting for 1.36% while institutional investors hold 69.37% of the
207 institutions hold shares in Akebia Therapeutics Inc. (AKBA), with 2.16M shares held by insiders accounting for 1.41% while institutional investors hold 69.41% of the